Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer Keeps IPR Winning Streak; Court Affirms Ruling On Tygacil Patent

Executive Summary

Federal Circuit finds Patent Trial and Appeal Board was correct in deciding composition patent on antibiotic was not obvious; Pfizer's inter partes review petition challenging Alzheimer's-related patent ended in settlement.


Related Content

Patents Face 'Real Threat' From Inter Partes Review; PTAB Open To Change
Biosimilar Litigation: Battles Continue Over Launch Notification, Access To FDA Info
New Patent Battleground: Inter Partes Reviews Besiege Innovators


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts